The Effect of a Gamified Neuropathy Management Application on Cancer Behavior in Cancer Patients Undergoing Chemotherapy

Launched by ANKARA YILDIRIM BEYAZIT UNIVERSITY · Dec 16, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a new approach to help cancer patients manage a condition called chemotherapy-induced neuropathy, which can cause pain and discomfort. The study will test a special app designed like a game to see if it can improve how patients feel and behave while they are undergoing chemotherapy. The goal is to make managing their symptoms more engaging and less stressful.

To participate in this study, you need to be between 18 and 65 years old, currently receiving chemotherapy, and have already completed your first treatment cycle. You should also be able to read and write, have a smartphone, and be willing to take part in the study. If you join, you'll use the app over a set period and complete some forms to share your experiences. This trial is not yet recruiting, so if you’re interested, keep an eye out for when it starts!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Undergoing chemotherapy treatment and have completed their first cycle.
• • Literate (able to read and write).
• • Able to use a smartphone.
• • Aged between 18 and 65 years.
• • Willing to participate in the study voluntarily.
• Exclusion Criteria:
• • Participants who do not use the application during the study period
• • Participants who fail to complete the data collection forms